CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $369,000 | -36.9% | 138,123 | +2.2% | 0.03% | -28.9% |
| Q4 2021 | $585,000 | +8.5% | 135,123 | +27.7% | 0.04% | +15.4% |
| Q3 2021 | $539,000 | +12.5% | 105,808 | +39.7% | 0.04% | +21.9% |
| Q2 2021 | $479,000 | +38.8% | 75,744 | +69.8% | 0.03% | +28.0% |
| Q1 2021 | $345,000 | -37.6% | 44,612 | -47.2% | 0.02% | -32.4% |
| Q4 2020 | $553,000 | -23.1% | 84,434 | -21.9% | 0.04% | -21.3% |
| Q3 2020 | $719,000 | -23.3% | 108,098 | -3.9% | 0.05% | -26.6% |
| Q2 2020 | $937,000 | +55.1% | 112,519 | +43.0% | 0.06% | +33.3% |
| Q1 2020 | $604,000 | -26.0% | 78,700 | -19.8% | 0.05% | -4.0% |
| Q4 2019 | $816,000 | +22.9% | 98,157 | +9.0% | 0.05% | +28.2% |
| Q3 2019 | $664,000 | – | 90,037 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |